Vestibular Rehabilitation With Intratympanic Drug Therapy in Meniere's Disease

• Status: Recruiting
• Trial end date: 2022-05-30
• Target enrollment: 0
• Participant gender: All

Summary

Intractable symptoms of Meniere's disease will be treated with intratympanic steroids.

At the same time intratympanic dexamethasone will be used to rescue hearing

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Combined Military Hospital Quetta
• Treatments: BB 1101; Dexamethasone; Dexamethasone acetate; Gentamicins

Criteria

Inclusion Criteria:

• All patients of unilateral Meniere's disease with severe vestibular symptoms

Exclusion Criteria:

• Bilateral disease, operated cases